title: Immune induction of human monocyte plasminogen activator. Characteristics of an assay for cell-mediated immunity.
abstract: We characterized immunologic induction of monocyte plasminogen activator (PA) to determine whether assay for PA induction reliably detected cell-mediated immunity (CMI). Mononuclear leukocytes (MNL) were incubated in teflon-lined culture tubes for 1-4 days in the presence or absence of phytohemagglutinin-P (PHA), concanavalin A (Con A) or Candida antigen. PA activity of the monocytes in those suspensions was then measured using a micro fibrin plate assay. Monocytes in stimulated MNL had more PA activity than monocytes in unstimulated MNL. Maximal differences between stimulated and unstimulated cells were seen after 2 days of culture. Dose-response studies demonstrated that PA induction occurred at submitogenic concentrations of stimuli. Peak induction was seen using suboptimally mitogenic concentrations of PHA, Con A and Candida antigen. PA induction in response to Candida stimulation corresponded with skin test results. More than 90% of healthy adults tested had positive assays to all stimuli. LPS, in picogram concentrations, induced PA activity in the absence of lymphocytes, but such induction was prevented by polymyxin B. Supernates from activated MNL also induced PA in purified monocytes. This indirect assay of PA induction was less sensitive than direct assay of the MNL. A standard indirect assay for leukocyte inhibitory factor (LIF) was also less sensitive than the direct PA induction assay. The direct PA induction assay is sensitive and convenient and requires small volumes of blood. It may prove valuable in in vitro analysis of cell-mediated immunity in health and disease.
authors.forename: C G
authors.initials: CG
authors.lastname: Ragsdale
authors.forename: K H
authors.initials: KH
authors.lastname: Swartz
authors.forename: J T
authors.initials: JT
authors.lastname: Cassidy
mesh_terms: D000946:Antigens, Fungal / Q000276:immunology; D002175:Candida / Q000276:immunology; D003208:Concanavalin A / Q000494:pharmacology; D004306:Dose-Response Relationship, Immunologic; D004731:Endotoxins / Q000494:pharmacology; D006801:Humans; D007111:Immunity, Cellular; D007961:Leukocyte Migration-Inhibitory Factors; D008213:Lymphocyte Activation / Q000187:drug effects; D008722:Methods; D009000:Monocytes / Q000276:immunology / Q000502:physiology*; D010835:Phytohemagglutinins / Q000494:pharmacology; D010960:Plasminogen Activators / Q000097:blood* / Q000276:immunology; D011113:Polymyxins / Q000494:pharmacology
chemical_list: D000946:Antigens, Fungal; D004731:Endotoxins; D007961:Leukocyte Migration-Inhibitory Factors; D010835:Phytohemagglutinins; D011113:Polymyxins; D003208:Concanavalin A; D010960:Plasminogen Activators